Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor F Tsigelny

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Oncoimmunology|February 7, 2019
APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapyAmélie Boichard, Timothy V Pham, Huwate Yeerna, et al.
Analytical Chemistry|August 24, 2021
Dynamic Cellular Cartography: Mapping the Local Determinants of Oligodendrocyte Transcription Factor 2 (OLIG2) Function in Live Cells Using Massively Parallel Fluorescence Correlation Spectroscopy Integrated with Fluorescence Lifetime Imaging Microscopy (mpFCS/FLIM)Sho Oasa, Aleksandar J Krmpot, Stanko N Nikolić, et al.
ACS Chemical Neuroscience|January 7, 2015
Molecular determinants of α-synuclein mutants' oligomerization and membrane interactionsIgor F Tsigelny, Yuriy Sharikov, Valentina L Kouznetsova, et al.
The FEBS Journal|March 27, 2007
Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synucleinIgor F Tsigelny, Pazit Bar-On, Yuriy Sharikov, et al.
Plos One|September 5, 2008
Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseasesIgor F Tsigelny, Leslie Crews, Paula Desplats, et al.
British Journal of Pharmacology|August 14, 2014
Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disordersWolf Wrasidlo, Leslie A Crews, Igor F Tsigelny, et al.
Journal of Alzheimer'S Disease : JAD|November 19, 2013
Structural diversity of Alzheimer's disease amyloid-β dimers and their role in oligomerization and fibril formationIgor F Tsigelny, Yuriy Sharikov, Valentina L Kouznetsova, et al.
The Oncologist|March 1, 2018
Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular CarcinomaSadakatsu Ikeda, Igor F Tsigelny, Åge A Skjevik, et al.
Plos Pathogens|November 25, 2025
Correction: Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concernGonzalo Almanza, Alex E Clark, Valentina Kouznetsova, et al.
Plos Pathogens|July 21, 2022
Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concernGonzalo Almanza, Alex E Clark, Valentina Kouznetsova, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Oncoimmunology|February 7, 2019
APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapyAmélie Boichard, Timothy V Pham, Huwate Yeerna, et al.
Analytical Chemistry|August 24, 2021
Dynamic Cellular Cartography: Mapping the Local Determinants of Oligodendrocyte Transcription Factor 2 (OLIG2) Function in Live Cells Using Massively Parallel Fluorescence Correlation Spectroscopy Integrated with Fluorescence Lifetime Imaging Microscopy (mpFCS/FLIM)Sho Oasa, Aleksandar J Krmpot, Stanko N Nikolić, et al.
ACS Chemical Neuroscience|January 7, 2015
Molecular determinants of α-synuclein mutants' oligomerization and membrane interactionsIgor F Tsigelny, Yuriy Sharikov, Valentina L Kouznetsova, et al.
The FEBS Journal|March 27, 2007
Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synucleinIgor F Tsigelny, Pazit Bar-On, Yuriy Sharikov, et al.
Plos One|September 5, 2008
Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseasesIgor F Tsigelny, Leslie Crews, Paula Desplats, et al.
British Journal of Pharmacology|August 14, 2014
Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disordersWolf Wrasidlo, Leslie A Crews, Igor F Tsigelny, et al.
Journal of Alzheimer'S Disease : JAD|November 19, 2013
Structural diversity of Alzheimer's disease amyloid-β dimers and their role in oligomerization and fibril formationIgor F Tsigelny, Yuriy Sharikov, Valentina L Kouznetsova, et al.
The Oncologist|March 1, 2018
Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular CarcinomaSadakatsu Ikeda, Igor F Tsigelny, Åge A Skjevik, et al.
Plos Pathogens|November 25, 2025
Correction: Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concernGonzalo Almanza, Alex E Clark, Valentina Kouznetsova, et al.
Plos Pathogens|July 21, 2022
Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concernGonzalo Almanza, Alex E Clark, Valentina Kouznetsova, et al.
Pageof 9